Mu Lan, Ren Chutong, Xu Jiangyue, Guo Can, Huang Jiangsheng, Ding Ke
Department of Thyroid Surgery, the Second Xiangya Hospital, Central South University, Changsha, China.
Department of Urology, Xiangya Hospital, Central South University, Changsha, China.
Gland Surg. 2021 Feb;10(2):729-738. doi: 10.21037/gs-20-757.
Total thyroidectomy (TT), near-total thyroidectomy (NT), and subtotal thyroidectomy (ST) are three surgical procedures for Graves' disease (GD) patients, but most previous studies have only evaluated the complications of TT versus ST or TT/NT versus ST; there is not a meta-analysis of NT versus TT, so whether NT is superior to TT for GD patients still unclear.
We comprehensively searched PubMed, Embase, Web of Science, and the Cochrane Library, without restriction to region, publication type, or language, on 10 June, 2020. We conducted this systematic review and meta-analysis of all included studies assessing the two surgical procedures.
In total, 528 cases were identified from two randomized controlled trials (RCTs) and three retrospective studies. The incidence of permanent hypoparathyroidism after NT was lower than with TT [odds ratio (OR), 0.22; 95% confidence interval (CI), 0.06-0.80; P=0.02], and there was no statistical difference in the recurrence of hyperthyroidism (OR, 0.33; 95% CI, 0.01-8.12; P=0.50) and other postoperative complications (P>0.05).
NT for GD was superior to TT regarding permanent hypoparathyroidism, but there was no significant difference in preventing recurrent hyperthyroidism, as well as the other postoperative complications.
全甲状腺切除术(TT)、近全甲状腺切除术(NT)和次全甲状腺切除术(ST)是Graves病(GD)患者的三种手术方式,但以往大多数研究仅评估了TT与ST或TT/NT与ST的并发症;尚无NT与TT的荟萃分析,因此NT对GD患者是否优于TT仍不清楚。
2020年6月10日,我们全面检索了PubMed、Embase、Web of Science和Cochrane图书馆,不受地区、出版物类型或语言限制。我们对所有纳入的评估这两种手术方式的研究进行了系统评价和荟萃分析。
总共从两项随机对照试验(RCT)和三项回顾性研究中确定了528例病例。NT后永久性甲状旁腺功能减退的发生率低于TT[比值比(OR),0.22;95%置信区间(CI),0.06 - 0.80;P = 0.02],甲状腺功能亢进复发率(OR,0.3३;95%CI,0.01 - 8.12;P = 0.50)和其他术后并发症方面无统计学差异(P>0.05)。
对于GD患者,NT在永久性甲状旁腺功能减退方面优于TT,但在预防甲状腺功能亢进复发以及其他术后并发症方面无显著差异。